Oncimmune raises €18.1M round
2 January 2018· Leeds, United Kingdom· health, biotechnology, diagnostics, ai, b2b, software_hardware
Investors
LeadSeneca Partners (Haydock)
Also participating
Innovate UKGenostics Australia
About Oncimmune
Stage
Post IPO
Headquarters
Leeds, United Kingdom
Founded
2002
Team Size
21–50
Sectors
healthbiotechnologydiagnosticsaib2bsoftware_hardware